All Stories

  1. Hydrogel Elastic Energy: A Stressor Triggering an Adaptive Stress‐Mediated Cell Response
  2. Prion-like Spreading of Disease in TDP-43 Proteinopathies
  3. The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activity
  4. Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors
  5. “A lactose-modified chitosan accelerates chondrogenic differentiation in mesenchymal stem cells spheroids”
  6. Assessing the Impact of Novel BRCA1 Exon 11 Variants on Pre-mRNA Splicing
  7. Changes in the expression of COI1, TIR1, and ERF1 genes and respective MiRNAs in Fusarium basal Rot-Stressed onion
  8. Age-Related Alternative Splicing: Driver or Passenger in the Aging Process?
  9. Cytotoxicity Profiles and Neuroprotective Properties of the Novel Ifenprodil Analogues as Sigma Ligands
  10. Immediate stress dissipation in dual cross-link hydrogels controls osteogenic commitment of mesenchymal stem cells
  11. Synthesis, Biological Evaluation and Computational Studies of New Hydrazide Derivatives Containing 1,3,4-Oxadiazole as Antitubercular Agents
  12. NOS1AP is a novel molecular target and critical factor in TDP-43 pathology
  13. Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands
  14. Unraveling the toxic effects mediated by the neurodegenerative disease–associated S375G mutation of TDP-43 and its S375E phosphomimetic variant
  15. Targets to watch in neuroinflammation: focus on RIPK1
  16. Cell environment shapes TDP-43 function with implications in neuronal and muscle disease
  17. Physiological tissue-specific and age-related reduction of mouse TDP-43 levels is regulated by epigenetic modifications
  18. Identification of Parkinson's disease biomarkers through RNA sequencing of peripheral blood leukocytes
  19. Characterization of the human TARDBP gene promoter
  20. Deferoxamine mesylate improves splicing and GAA activity of the common c.-32-13T>G allele in late-onset PD patient fibroblasts
  21. γ- and δ-lactones as fumarate esters analogues and their neuroprotective effects
  22. From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline
  23. Synthesis, Cytotoxicity Evaluation, and Computational Insights of Novel 1,4-Diazepane-Based Sigma Ligands
  24. Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents
  25. Dysregulation of TDP‐43 intracellular localization and early onset ALS are associated with a TARDBP S375G variant
  26. New piperidine-based derivatives as sigma receptor ligands. Synthesis and pharmacological evaluation
  27. Systematic Analysis of Gene Expression Profiles Controlled by hnRNP Q and hnRNP R, Two Closely Related Human RNA Binding Proteins Implicated in mRNA Processing Mechanisms
  28. Abstract 2382: In silico/in vitro studies of novel hot spot mutations in BCR-ABL1: A multidisciplinary approach to shed a new light on TKI resistance
  29. RhoGAPp190: A potential player in tbph-mediated neurodegeneration in Drosophila
  30. Essential role of hippocampal noradrenaline in the regulation of spatial working memory and TDP-43 tissue pathology
  31. Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease
  32. Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells
  33. Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease
  34. Computer-assisted design, synthesis, binding and cytotoxicity assessments of new 1-(4-(aryl(methyl)amino)butyl)-heterocyclic sigma 1 ligands
  35. TBPH/TDP-43 modulates translation of Drosophila futsch mRNA through an UG-rich sequence within its 5′UTR
  36. New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition
  37. Antimycobacterial activity of new N 1 -[1-[1-aryl-3-[4-(1 H -imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives
  38. A novelDrosophilamodel of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects
  39. Exome sequencing of a colorectal cancer family reveals shared mutation pattern and predisposition circuitry along tumor pathways
  40. TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways
  41. Knockdown of MVK does not lead to changes in NALP3 expression or activation
  42. A novel anti-aldolase C antibody specifically interacts with residues 85–102 of the protein
  43. Evolutionarily Conserved Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A/B Proteins Functionally Interact with Human and Drosophila TAR DNA-binding Protein 43 (TDP-43)
  44. Targeting RNA Binding Proteins Involved in Neurodegeneration
  45. TDP-43 high throughput screening analyses in neurodegeneration: Advantages and pitfalls
  46. Role of Pseudoexons and Pseudointrons in Human Cancer
  47. Tirasemtiv (CK-2017357)
  48. Florbetapir F 18 for brain imaging of beta-amyloid plaques
  49. Small Cytoplasmic Ribonucleoproteins
  50. Tirasemtiv (CK-2017357)
  51. Splicing in the RNA World
  52. Drosophila Answers to TDP-43 Proteinopathies
  53. TDP-43 Regulates Drosophila Neuromuscular Junctions Growth by Modulating Futsch/MAP1B Levels and Synaptic Microtubules Organization
  54. TDP-43 regulates its mRNA levels through a negative feedback loop
  55. G runs in Cystathionine β-Synthase c.833C/c.844_845ins68 mRNA are splicing silencers of pathogenic 3′ splice sites
  56. Neuropeptides in saliva of subjects with burning mouth syndrome: a pilot study
  57. Nuclear factor TDP-43 can affect selected microRNA levels
  58. Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo
  59. Dissecting the splicing mechanism of the Drosophila editing enzyme; dADAR
  60. Thrombopoietin and its splicing variants: Structure and functions in thrombopoiesis and beyond
  61. Origin and evolution of the c.844_845ins68/c.833T>C mutations within the cystathionine β-synthase gene in great apes
  62. Aberrant 5′ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization
  63. Complex splicing control of the human Thrombopoietin gene by intronic G runs
  64. Photodynamic Therapy of Subfoveal Choroidal Neovascularization Secondary to Reticular Pattern Dystrophy: Three-Year Results of an Uncontrolled, Prospective Case Series
  65. Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene
  66. Human, Drosophila, and C.elegans TDP43: Nucleic Acid Binding Properties and Splicing Regulatory Function
  67. Corrigendum
  68. hnRNP H binding at the 5' splice site correlates with the pathological effect of two intronic mutations in the NF-1 and TSH  genes
  69. An Exonic Splicing Enhancer Offsets the Atypical GU-rich 3′ Splice Site of Human Apolipoprotein A-II Exon 3
  70. Genetic characterization of myeloperoxidase deficiency in Italy
  71. Identification and Subcellular Localization of Neuronal Calcium Sensor-1 (NCS-1) in Human Neutrophils and HL-60 Cells
  72. Genetic heterogeneity in Malattia Leventinese
  73. Regulation of 3′ Splice Site Selection in the 844ins68 Polymorphism of the Cystathionine β-Synthase Gene
  74. Minor Role for BRCA2 (Exon11) and p53 (Exon 5–9) Among Sudanese Breast Cancer Patients
  75. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping
  76. Expression and characterization of recombinant human eosinophil peroxidase
  77. Functional Characterization of the Novel Mutation IVS 8 (−11delC) (−14T>A) in the Intron 8 of the Glucocerebrosidase Gene of Two Italian Siblings with Gaucher Disease Type I
  78. Splicing Factors Induce Cystic Fibrosis Transmembrane Regulator Exon 9 Skipping through a Nonevolutionary Conserved Intronic Element
  79. Myeloperoxidase (MPO) and Eosinophil Peroxidase (EPO) Deficiency in the Region Friuli-Venezia Giulia of North-Eastern Italy
  80. The A/G polymorphism in the −78 position of the apolipoprotein A-I promoter does not have a direct effect on transcriptional efficiency
  81. Hereditary eosinophil peroxidase deficiency: immunochemical and spectroscopic studies and evidence for a compound heterozygosity of the defect.
  82. cDNA clones of myeloperoxidase (MPO) and eosinophil peroxidase (EPO) from human blood mononuclear cells differentiated into granulocyte precursors in liquid cultures